Effects of Rosiglitazone, Glyburide, and Metformin on β-Cell Function and Insulin Sensitivity in ADOPT
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial monotherapy with rosiglitazone provided superior durability of glycemic control compared with metformin and glyburide in patients with recently diagnosed type 2 diabetes. Herein, we examine measures of β-cell function and insulin sensitivity from an oral glucose tolerance test (OGTT) over a 4-year period among the three treatments. RESEARCH DESIGN AND METHODS: Recently diagnosed, drug-naïve patients with type 2 diabetes (4,360 total) were treated for a median of 4.0 years with rosiglitazone, metformin, or glyburide and were examined with periodic metabolic testing using an OGTT. RESULTS: Measures of β-cell function and insulin sensitivity from an OGTT showed more favorable changes over time with rosiglitazone versus metformin or glyburide. Persistent improvements were seen in those who completed 4 years of monotherapy and marked deterioration of β-cell function in those who failed to maintain adequate glucose control with initial monotherapy. CONCLUSIONS: The favorable combined changes in β-cell function and insulin sensitivity over time with rosiglitazone appear to be responsible for its superior glycemic durability over metformin and glyburide as initial monotherapy in type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This differential effect was largely related to the impact on β-cell function11,138.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [11]
Experimental — accuracy not yet measuredIn the citing paper
“Further progressive deterioration of β-cell function accounts for the evolving natural history of the disease from impaired glucose tolerance to type 2 diabetes10,11.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SNEDECOR, G. W. (1939) · Soil Science · doi:10.1097/00010694-193902000-00006 · Cited by 19,359
Applied Linear Statistical Models
Ziegel, E. R., Neter, J., Wasserman, W., & Kutner, M. (1992) · Technometrics · doi:10.2307/1269588 · Cited by 9,907
Regression Diagnostics: Identifying Influential Data and Sources of Collinearity
Belsley, D. A., Kuh, E., & Welsch, R. E. (1980) · Wiley Series in Probability and Statistics · doi:10.1002/0471725153 · Cited by 7,297
Applied Linear Statistical Models
(1997) · Technometrics · doi:10.1080/00401706.1997.10485141 · Cited by 7,185
Regression Diagnostics -- Identifying Influential Data and Sources of Collinearity
Beaumont, C. D., Belsley, D. A., Kuh, E., & Welsch, R. E. (1981) · The Journal of the Operational Research Society · doi:10.2307/2581267 · Cited by 6,359
Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Self-citationKahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166
Self-citationWeyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940 · cited 1×
“This is best demonstrated by the loss of b-cell function over time in individuals who progress from states of impaired glucose metabolism to diabetes (14,15).”
BackgroundU.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Research works printed but not linked: 1
- Faulenbach, 2008, Prevalence of negative insulinogenic index by glucose tolerance in three different cohorts, Diabetes, 57, A669
Cited by
Items 101–200 of 249
The impact of bariatric surgery on insulin-treated type 2 diabetes patients
Lemus, R., Karni, D., Hong, D., Gmora, S. B., Breau, R., & Anvari, M. (2017) · Surgical Endoscopy · doi:10.1007/s00464-017-5777-5 · Cited by 21
King, A. B., Montanya, E., Pratley, R. E., Blonde, L., Svendsen, C. B., Donsmark, M., & Sesti, G. (2012) · Endocrine Practice · doi:10.4158/ep12232.or · Cited by 22
Smith, K., Taylor, G., Walker, M., Brunsgaard, L. H., Davies, K. A. B., Stevenson, E., & West, D. J. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad069 · Cited by 23
Rasouli, N., Younes, N., Ghosh, A., Albu, J., Cohen, R. M., DeFronzo, R. A., Diaz, E., Kassem, L. S., Luchsinger, J. A., McGill, J. B., et al. (2024) · Diabetes Care · doi:10.2337/dc23-1070 · Cited by 27
Self-citationRasouli, N., Younes, N., Utzschneider, K. M., Inzucchi, S. E., Balasubramanyam, A., Cherrington, A., Ismail‐Beigi, F., Cohen, R. M., Olson, D. E., DeFronzo, R. A., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1787 · Cited by 22
Self-citationKahn, S. E., Mather, K. J., Arslanian, S. A., Barengolts, E., Buchanan, T. A., Caprio, S., Ehrmann, D. A., Hannon, T. S., Marcovina, S. M., Nadeau, K. J., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0460 · Cited by 22
Self-citationPractical combination therapy based on pathophysiology of type 2 diabetes
LEVIN, P. A. (2016) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s109216 · Cited by 21
Prato, S. D., & CHILTON, R. J. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13169 · Cited by 21
Targeting beta-cell preservation in the management of type 2 diabetes
Boughton, C. K., Munro, N. M., & Whyte, M. (2017) · British Journal of Diabetes · doi:10.15277/bjd.2017.148 · Cited by 24
Borges, R. D. S., Conegundes, A. F., de Paula, L. H., dos Santos, R. L. C., Alves, S. N., Machado, R. A., Viana, I. B., & Silva, A. C. S. E. (2024) · Pediatric Diabetes · doi:10.1155/2024/6295345 · Cited by 23
Choice of early treatment regimen and impact on β-cell preservation in type 2 diabetes
Mudaliar, S. R. D. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12154 · Cited by 19
Okazaki‐Hada, M., Moriya, A., Nagao, M., Oikawa, S., Fukuda, I., & Sugihara, H. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13312 · Cited by 20
Type 2 diabetes in children and adolescents: Challenges for treatment and potential solutions
Jia, I. L. J., Zampetti, S., Pozzilli, P., & Buzzetti, R. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111879 · Cited by 31
Rascati, K. L., Richards, K., Lopez, D. A., Cheng, L., & Wilson, J. P. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12103 · Cited by 17
Sjöstrand, M., Carlson, K., Arnqvist, H. J., Guðbjörnsdóttir, S., Landin‐Olsson, M., Lindmark, S., Nyström, L., Svensson, M. K. E., Eriksson, J. W., & Bolinder, J. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12116 · Cited by 16
Wang, Y., Xu, W., Mak, I. L., Chin, W. Y., Yu, E. Y. T., Lam, C. L. K., & Wan, E. Y. F. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101999 · Cited by 18
Annual decline in β‐cell function in patients with type 2 diabetes in China
Gao, Z., Yan, W., Fang, Z., Zhang, Z., Li, Y., Wang, X., Jia, Z., Zhu, Y., Miller, J. D., Yuan, X., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3364 · Cited by 15
Significant retinopathy in young-onset type 2 vs. type 1 diabetes: a clinical observation
Song, S. H. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12789 · Cited by 17
Cravalho, C. K. L., Meyers, A. G., Mabundo, L. S., Courville, A. B., Yang, S. B., Cai, H., Dai, Y., Walter, M. F., Walter, P. J., Sharma, S., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05236-y · Cited by 18
Utility of Hypoglycemic Agents to Treat Asthma with Comorbid Obesity
Ge, D., Foer, D., & Cahill, K. N. (2022) · Pulmonary Therapy · doi:10.1007/s41030-022-00211-x · Cited by 14
Heise, T., Larbig, M., Patel, S., Seck, T. L., Hehnke, U., Woerle, H. J., & Dugi, K. A. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12312 · Cited by 14
Fu, A. Z., Qiu, Y., Davies, M. J., & Engel, S. S. (2012) · Diabetes Therapy · doi:10.1007/s13300-012-0012-9 · Cited by 14
Obesity, Type 2 Diabetes and Beta Cell Failure: An Asian Perspective
Saisho, Y. (2014) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.s1-008 · Cited by 18
Subramanian, G., Shanmugamprema, D., Subramani, R., Muthuswamy, K., Ponnusamy, V., Tankay, K., Velusamy, T., Vasanth, K., & Selvakumar, S. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202001224 · Cited by 14
Approach to the Patient: Youth-Onset Type 2 Diabetes
Hitt, T. A., Hannon, T. S., & Magge, S. N. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad482 · Cited by 15
Current Perspectives for Treating Adolescents with Obesity and Type 2 Diabetes: A Review
Niechciał, E., Wais, P., Bajtek, J., & Kędzia, A. W. (2024) · Nutrients · doi:10.3390/nu16234084 · Cited by 26
What's next after metformin? focus on sulphonylurea: add-on or combination therapy
Lim, P. C., & Chong, C. P. (2015) · Pharmacy Practice · doi:10.18549/pharmpract.2015.03.606 · Cited by 20
Intensive Therapy in Newly Diagnosed Type 2 Diabetes: Results of a 6-Year Randomized Trial
Harrison, L., ADAMS-HUET, B. A., Li, X., Raskin, P., & Lingvay, I. (2014) · Journal of Investigative Medicine · doi:10.2310/jim.0000000000000068 · Cited by 14
Russo, G. T., Giorda, C. B., Cercone, S., Cosmo, S. D., Nicolucci, A., Cucinotta, D., & the BetaDecline Study Group (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3016 · Cited by 13
Diabetes tipo 2 infantojuvenil
Bernal, M., & Aguilar, J. M. V. (2018) · Revista Clínica Española · doi:10.1016/j.rce.2018.03.020 · Cited by 18
Risk of developing chronic kidney disease in young-onset Type 2 diabetes in Korea
Lee, J., Lee, S., Yoon, K., Cho, J., Han, K., & Yang, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-36711-2 · Cited by 13
Recent Glycemia Is a Major Determinant of β-Cell Function in Type 2 Diabetes Mellitus
Kim, J. Y., Lee, J. Y., Kim, S. G., & Kim, N. H. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0359 · Cited by 20
Incorporating Incretin-Based Therapies into Clinical Practice for Patients with Type 2 Diabetes
Tibaldi, J. M. (2014) · Advances in Therapy · doi:10.1007/s12325-014-0100-5 · Cited by 14
Unmet Needs in the Treatment of Childhood Type 2 Diabetes: A Narrative Review
Tamborlane, W. V., & Shehadeh, N. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02642-7 · Cited by 12
A drug and disease model for lixisenatide, a GLP‐1 receptor agonist in type 2 diabetes
Wilkins, J. J., Dubar, M., Sébastien, B., & Laveille, C. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.192 · Cited by 12
Marathe, C. S., Rayner, C. K., Lange, K. M., Bound, M. J., Wishart, J. M., Jones, K. L., Kahn, S. E., & Horowitz, M. (2017) · Physiological Reports · doi:10.14814/phy2.13122 · Cited by 12
Self-citationBeta‐cell function in type 2 diabetes ( T2DM ): Can it be preserved or enhanced?
Kassem, L. S., Rajpal, A., Barreiro, M. V. E., & Ismail‐Beigi, F. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13446 · Cited by 16
The MAIKO Study group, Kondo, Y., Harada, N., Hamasaki, A., Kaneko, S., Yasuda, K., Ogawa, E., Harashima, S., Yoneda, H., Fujita, Y., et al. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0131-y · Cited by 13
Long-term studies of treatments for type 2 diabetes
Caballero, A. E. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2017.1265417 · Cited by 12
Templin, A. T., Meier, D. T., Willard, J. R., Wolden‐Hanson, T., Conway, K. A., Lin, Y., Gillespie, P. J., Bokvist, K. B., Attardo, G., Kahn, S. E., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4695-y · Cited by 12
Self-citationYoung‐onset type 2 diabetes—Epidemiology, pathophysiology, and management
Luk, A. O. Y., Wu, H., Fan, Y., Fan, B., O, C. K., & Chan, J. C. N. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70081 · Cited by 13
Vajravelu, M. E., Hitt, T. A., Amaral, S. G., Katz, L. E. L., Lee, J. M., & Kelly, A. T. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13232 · Cited by 10
Frederico, M. J. S., Cipriani, A., Heim, J. B. A., Mendes, A. K. B., Aragón, D. M., Gaspar, J. M., de Alencar, N. M. N., & Silva, F. R. M. B. (2023) · Pharmaceuticals · doi:10.3390/ph16081167 · Cited by 11
Utzschneider, K. M., Younes, N., Butera, N. M., Balasubramanyam, A., Bergenstal, R. M., Barzilay, J. I., Desouza, C. V., DeFronzo, R. A., Elasy, T. A., Krakoff, J. A., et al. (2024) · Diabetes Care · doi:10.2337/dc23-1059 · Cited by 12
Self-citationOptimizing management of glycaemia
Chatterjee, S., Khunti, K., & Davies, M. J. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.06.002 · Cited by 15
Treating Patients With Diabetes of Long Duration: GLP-1 Receptor Agonists and Insulin in Combination
Moghissi, E. S. (2014) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2014.086 · Cited by 10
Liu, X., Cai, S., Yi, J., & Chu, C. (2023) · Nutrients · doi:10.3390/nu15184080 · Cited by 11
Boland, B. B., Alarcón, C., Ali, A., & Rhodes, C. J. (2015) · Islets · doi:10.1080/19382014.2015.1073435 · Cited by 9
Using Oral Challenge Testing to Assess Insulin Action and Secretion With Mathematical Modeling
Staten, M. A., & Kelley, D. E. (2014) · Diabetes · doi:10.2337/db13-1839 · Cited by 12
Kozlovski, P., Bhosekar, V., & Foley, J. E. (2017) · Vascular Health and Risk Management · doi:10.2147/vhrm.s125850 · Cited by 9
Singh, A. K., Misra, A., Das, A. K., Behl, A., Srivastava, A., Paneerselvam, A., Chidambaram, B., Saboo, B., Sethi, B. K., Makkar, B. M., et al. (2023) · Journal of the Association of Physicians of India · doi:10.59556/japi.71.0422 · Cited by 12
Federici, M. O., Gentilella, R., Corcos, A., Torre, E., & Genovese, S. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3434 · Cited by 8
Lupoli, R., Lembo, E., Giosuè, A., Schiavo, L., & Capaldo, B. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.02.019 · Cited by 10
Çaylı, S., Alimoğulları, E., Pişkin, İ., Bilginoğlu, A., & Nakkaş, H. (2021) · Journal of Molecular Histology · doi:10.1007/s10735-021-10013-1 · Cited by 8
Thakur, M. S., Deshmukh, K. N., Dey, A., Ranjan, D., Goyal, A., & Jachak, S. M. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118423 · Cited by 9
Patel, Y. R., Kirkman, M. S., Considine, R. V., Hannon, T. S., & Mather, K. J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2056 · Cited by 6
Methods to Assess In Vivo Insulin Sensitivity and Insulin Secretion
Bonadonna, R. C., Boselli, L., Dei, A., & Trombetta, M. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_11-1 · Cited by 9
Ishigaki, H., Yoshida, A., Araki, O., Kimura, T., Tsunekawa, K., Shoho, Y., Nara, M., Aoki, T., Ogiwara, T., & Murakami, M. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.98 · Cited by 8
Intervention with Therapeutic Agents, Understanding the Path to Remission in Type 2 Diabetes
Hao, S., Umpierrez, G. E., Daley, T. C., & Vellanki, P. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.07.003 · Cited by 7
Hannon, T. S., Edelstein, S. L., Arslanian, S. A., Caprio, S., Zeitler, P. S., Buchanan, T. A., Ehrmann, D. A., Mather, K. J., Tripputi, M., Kahn, S. E., et al. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13129 · Cited by 7
Self-citationKramer, C. K., & Zinman, B. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw158 · Cited by 7
Self-citationStriving for early effective glycaemic and weight management in type 2 diabetes: A narrative review
CHENG, A. Y. Y., Heine, R. J., Prato, S. D., Green, J. B., Thieu, V. T., & Zeytinoglu, M. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16206 · Cited by 7
Yuan, H., Weng, C., Yang, Y., Huang, L., & Xing, X. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.08.014 · Cited by 6
Johnson, A. W., & Shubrook, J. H. (2013) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2013.058 · Cited by 6
Cai, X., Chen, Y., Zhao, J., Shan, Z., Qiu, M.-C., Li, C., Gu, W., Tian, H., Yang, H.-Z., Xue, Y., et al. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.156735 · Cited by 6
Managing Diabetes From First Diagnosis
Kruger, D. (2012) · The diabetes educator · doi:10.1177/0145721712450619 · Cited by 3
Top, W. M. C., Stehouwer, C. D. A., Lehert, P., & Kooy, A. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13123 · Cited by 6
Mather, K. J., Chen, M. E., & Hannon, T. S. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107589 · Cited by 6
Infant-juvenile type 2 diabetes
Bernal, M., & Aguilar, J. M. V. (2018) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2018.03.015 · Cited by 5
The current status of serum insulin measurements and the need for standardization
Rohlfing, C. L., Petroski, G. F., Hatten-Beck, M., Hanson, S. E., Hoofnagle, A. N., Little, R. R., & Kabytaev, K. (2025) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2025-0552 · Cited by 6
Cheng, J., Li, J., Xin, Y., & Zhang, D. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1602796 · Cited by 5
Wen, W., Huang, H., Lin, H.-C., Lo, W., Chen, S., & Lee, M. (2022) · Nutrients · doi:10.3390/nu14020320 · Cited by 5
Pharmaceutical Interventions for Diabetes Prevention in Patients at Risk
Chatterjee, S., Davies, M. J., & Khunti, K. (2017) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-017-0239-y · Cited by 5
Zuo, P., Shi, J., Yan, J., Yang, L., Liu, C., Li, Y., & Lou, Q. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0881-9611 · Cited by 7
Novel Approaches to Restore Pancreatic Beta-Cell Mass and Function
Welters, A., & Lammert, E. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_474 · Cited by 5
Bariatric/Metabolic Surgery for Diabetes: Lessons From the Past and Present
Purnell, J. Q., & Wolfe, B. M. (2019) · Diabetes Care · doi:10.2337/dci18-0031 · Cited by 5
Bloomgarden, Z. T. (2011) · Diabetes Care · doi:10.2337/dc11-0591 · Cited by 5
Lai, Y.-C., Li, H., Wu, T.-J., Jeng, C.-Y., & Chuang, L. (2014) · PPAR Research · doi:10.1155/2014/917823 · Cited by 5
Personalized approach for type 2 diabetes pharmacotherapy: where are we and where do we need to be?
Abdul‐Ghani, M. A., & DeFronzo, R. A. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1967319 · Cited by 5
Wang, Y., Chin, W. Y., Lam, C. L. K., & Wan, E. Y. F. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15856 · Cited by 6
Loss of β‐cell identity in human islets treated with glibenclamide
Fernández, C., Nacher, M., Rivera, K., Marín‐Cañas, S., Sorribas, M., Moreno‐González, G., Estil·les, E., José, P. S., Téllez, N., & Montanya, E. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16632 · Cited by 4
Integrating medical and surgical therapies to optimize the outcomes of type 2 diabetes
Ceccarini, G., Ciccarone, A. M., Santini, F., & Prato, S. D. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.01.035 · Cited by 4
Xiong, G.-X., Xiong, L., & Li, X. (2016) · Laser Physics · doi:10.1088/1054-660x/26/9/095605 · Cited by 4
Masulli, M., Pepa, G. D., Cocozza, S., Capasso, M., Pignataro, P., Vitale, M., Gastaldelli, A., Russo, M., Dolce, P., Riccardi, G., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3392 · Cited by 4
Boye, K. S., Lage, M. J., & Kiljanski, J. I. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01051-9 · Cited by 5
Hong, K.-F., Liu, P., Zhang, W., Gui, D., & Xu, Y. (2023) · Journal of Integrative and Complementary Medicine · doi:10.1089/jicm.2022.0767 · Cited by 6
Pediatric Clinical Endpoint and Pharmacodynamic Biomarkers: Limitations and Opportunities
Dinh, J., Hosey, C. M., & Jones, B. L. (2020) · Pediatric Drugs · doi:10.1007/s40272-019-00375-1 · Cited by 6
Abnormalities of Insulin Secretion and β‐Cell Defects in Type 2 Diabetes
Prato, S. D., Bianchi, C., & Daniele, G. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch12 · Cited by 14
Metabolic-Bariatric Surgery for Type 2 Diabetes: Time(ing) for a Change
Purnell, J. Q. (2024) · Diabetes · doi:10.2337/dbi23-0022 · Cited by 3
Piona, C. A., Mozzillo, E., Tosco, A., Zusi, C., Emiliani, F., Volpi, S., Candia, F. D., Raia, V., Boselli, M. L., Trombetta, M., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae474 · Cited by 5
Kar, D., Byng, R., Sheikh, A., Nath, M., Zabeen, B., Kar, S., Banu, S., Sarker, M. H. R., Khan, N., Acharjee, D., et al. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04090-7 · Cited by 5
Rathmann, W., Straßburger, K., Bongaerts, B. W. C., Bobrov, P., Kuß, O., Müssig, K., Markgraf, D. F., Szendroedi, J., Herder, C., Roden, M., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12894 · Cited by 3
The W orld C ongress of I nsulin R esistance, D iabetes and C ardiovascular D isease ( WCIRDC )
Bloomgarden, Z. T. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13349 · Cited by 4
Hanefeld, M., Fleischmann, H., Liebl, A., & Siegmund, T. (2019) · Diabetologie und Stoffwechsel · doi:10.1055/a-0820-1665 · Cited by 3
Postprandial C-peptide Index: The Best Marker of Beta Cell Function?
Saisho, Y. (2014) · International Journal of Diabetes & Clinical Diagnosis · doi:10.15344/2394-1499/2014/102 · Cited by 2
An Expert Opinion on the Management of Type 2 Diabetes Mellitus in Children and Adolescents
Rajput, R., Jha, S. K., Panda, J. K., Subrahmanyam, A. K., & Das, S. (2021) · Journal of Diabetology · doi:10.4103/jod.jod_71_21 · Cited by 3
D’Alessio, D. A., & Kahn, S. E. (2025) · Diabetes · doi:10.2337/dbi24-0049 · Cited by 2
Self-citationMiyamoto, M., Miya, A., Nakamura, A., Takahashi, Y., Yamauchi, Y., Yanagiya, S., Takase, T., Ono, M., Takahashi, K., Okada, K., et al. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70245 · Cited by 2
Patel, S., Zihan, Y., & Remedi, M. S. (2026) · MedComm · doi:10.1002/mco2.70588 · Cited by 2
Yao, J., Zhang, M., Zhang, X., & Zhang, J. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01369-6 · Cited by 2
Metadata
- Authors
- Kahn, S. E., Lachin, J. M., Zinman, B., Haffner, S. M., Aftring, R. P., Paul, G., Kravitz, B. G., Herman, W. H., Viberti, G., Holman, R. R., & and the ADOPT Study Group
- Affiliations
- University of Washington (US)
- George Washington University (US)
- Mount Sinai Hospital (CA)
- San Antonio Texas
- GlaxoSmithKline (United States) (US)
- University of Michigan (US)
- King's College London (GB)
- University of Oxford (GB)
- Corresponding author
- Kahn, Steven E.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-04-23
- Volume
- 60
- Issue
- 5
- Pages
- 1552-1560
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3292330
- OpenAlex
- W2111473023
- Cited by
- 249
- References
- 25
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 21 · 2023: 20 · 2022: 11 · 2021: 17 · 2020: 21 · 2019: 11 · 2018: 19 · 2017: 21 · 2016: 19 · 2015: 10 · 2014: 24 · 2013: 18 · 2012: 15
- FWCI
- 15.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- GlaxoSmithKline
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- rosiglitazone, metformin, glibenclamide, type 2 diabetes, beta-cell function, insulin sensitivity, oral glucose tolerance test, ADOPT trial, thiazolidinediones, sulfonylureas
- MeSH terms
- Rosiglitazone, Aged, Diabetes Mellitus, Type 2, Female, Glyburide, Humans, Hypoglycemic Agents, Insulin Resistance, Male, Metformin, Middle Aged, Thiazolidinediones, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.